Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)UnknownNCT05595109
What this trial is testing

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Who this might be right for
Breast CancerPeripheral NeuropathyCardiac Toxicities+2 more
Tanta University 56
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Not applicableNot Yet RecruitingNCT07419711
What this trial is testing

Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity

Who this might be right for
Chemotherapy-induced CardiotoxicityBreast Cancer
Nazarbayev University 120
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Large-scale testing (Phase 3)Ended earlyNCT00247975
What this trial is testing

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Who this might be right for
Heart Failure
Ottawa Heart Institute Research Corporation 36
Testing effectiveness (Phase 2)Study completedNCT07668076
What this trial is testing

The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Damanhour University 44
Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Testing effectiveness (Phase 2)Looking for participantsNCT07245069
What this trial is testing

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Who this might be right for
Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)+2 more
University Medical Centre Ljubljana 100
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Large-scale testing (Phase 3)UnknownNCT02236806
What this trial is testing

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Who this might be right for
Breast CancerCardiotoxicity
Azienda Ospedaliero-Universitaria Careggi 262